Background: Lactate dehydrogenase (LDH) is a tetrameric enzyme that catalyzes the interconversion of pyruvate to L-lactate. The importance of this enzyme is because LDH isoenzymes are involved in cancer, heart, and liver diseases. Inhibition of this enzyme can help prevent and treat different diseases. Morin is a flavonoid found in the Moraceae family and scopoletin is a coumarin found in Scopolia genus. Objectives: The aim of this study was to determine the effect of morin and scopoletin as two natural products on the activity and structure of lactate dehydrogenase enzyme. Methods: Morin and scopoletin were examined for inhibition of the activity of LDH in 100 mM sodium phosphate buffer pH 7.5, at room temperature using UV-V spectrophotometry. Fluorescence spectroscopy was used to characterize protein structural changes in the presence of morin and scopoletin. Results: Km and Vmax of LDH for pyruvate were 11.69 mM and 1.258 mM/min, respectively. The kinetic results showed that morin
Background
Lactate dehydrogenase (LDH, EC 1.1.1.27) is a key enzyme in anaerobic respiration that catalyzes the reversible conversion of pyruvate to lactate in the presence of NADH. Two major forms of LDH found in a wide range of organisms are the A form (A4-LDH), found predominantly in anaerobic tissues, such as skeletal muscle and liver, and the H form (B4-LDH), which predominates mainly aerobic tissues, such as the heart (1, 2) . A third type has also been identified, the X form, which appears to be restricted to the testes (3). The LDH-A and LDH-B subunits are similar in size and share 75% sequence identity yet have different catalytic properties; the A subunit preferentially converts pyruvate to lactate, while for the B form the opposite is true. They organize four distinct enzyme classes with tetrameric structure; A4, A3B, A2B2, B3A, and B4 that are different isoenzymes of LDH (4) . Furthermore, LDH is a biomarker of different diseases, thus this enzyme is an interesting enzyme for scientists.
Since metabolism is impaired in cancer cells, these cells are dependent on anaerobic metabolism to survive. Lactate dehydrogenase inhibition could be the target of different cancer therapy studies. Inhibition of LDH devastate glucose metabolism in cancer cells without affecting the energetic balance of normal cells. Inactivation of LDH enzyme in the presence of different natural and synthetic components has been studied. For example, Galloflavin is a synthetic compound that inhibits both A and B isoforms of LDH and hinders the proliferation of tumor cells by blocking glycolysis. The inhibition is a mixed type for pyruvate and lactate (5) . FX11 [3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid] is another inhibitor of LDH that used for treatment of pancreatic cancer in vivo and in vitro (2) . Genistein is another LDH inhibitor that inhibits the activity of enzyme due to competition with NADH for the enzyme binding (6) . and activity changes. When cysteine residues of LDH react with p_chloromercuribenzoate (pCMB), the enzyme partially unfolds (7) . The effect of o-phthalaldehyde (opta) on the structure and activity of Lactate dehydrogenase was investigated. Opta not only inhibited this enzyme but also changed the structure of lactate dehydrogenase and induced partial unfolding (8) .
Phenolic compounds, like flavonoids and coumarins, are a wide class of plant compounds that present in almost all foods of plant origin. These compounds possess several biological properties and cause protection against different diseases, especially cardiovascular diseases and different cancers. Various researches demonstrated that their pharmacological activities depend on their antioxidant properties (9) . Morin (2', 3, 4', 5, 7-pentahydroxyflavone), a natural flavonoid, can be found in almond, fig, other Moraceae family and also some herbal medicines. Recently cell protecting effect of morin against hydrogen peroxideinduced oxidative stress was reported. For example, in irradiated cells that produce ROS, ROS scavenging might be the reason of morin cytoprotective effects against the damage caused by gamma rays (10) . Morin has been introduced as an inhibitor of xanthine oxidase, urate oxidase, amino peptidase N, phosphatidil inositol phosphate kinase, and malic enzymes (11) (12) (13) (14) . Scopoletin (6-methoxy-7-hydroxy coumarin) is one of the important members of the coumarin group. It has shown that scopoletin has anti-bacterial and antifungal properties (15, 16) . Scopoletin could have an important role in the management of many symptoms and diseases, such as convulsions, inflammation, rheumatic pains, and leprosy (17) . Scopoletin has shown strong inhibition of acetylcholinesterase and thus it is a potential candidate for Alzheimer's disease treatment (18) . Furthermore, scopoletin has been introduced as inhibitor of β-glucuronidase, peroxidase, acetylcholinesterase, and mono amine oxidase (19) (20) (21) (22) .
Objectives
Because of the clinical benefits of morin and scopoletin as well as the importance of lactate dehydrogenase enzyme in cancer treatment, lactate dehydrogenase activity and its structural changes was investigated in the presence of morin and scopoletin in the current study.
Methods
In this experimental research, rabbit muscle LDH (L-1254), sodium pyruvate (P2256), NADH (N8129), morin (M4008), and scopoletin (S2500) were obtained from Sigma-Aldrich. Ethanol and phosphate buffer were purchased from Merck. All solutions were prepared with distilled water.
LDH Activity and Inhibition Assay (Kinetic Studies)
The LDH samples (0.75 u/mL) in 100 mM sodium phosphate buffer (pH 7.5) were freshly prepared and assayed by spectrophotometer, according to the sigma protocol (23) . One unit will reduce 1.0 µmole of pyruvate to L-lactate per minute. The absorbance change produced by 0.13 mM NADH oxidation was recorded at 340 nm. The activity was determined at 0.3, 0.6, 0.9, 1.3, 1.9, 2.3, 2.6, 2.9, 3.3, 5, 6.6, and 8 mM pyruvate. The LDH activity was investigated at 1.9, 3.3, 6.7, and 8.2 µM of morin and at 0.3, 0.6, 1.3, 1.9, and 2.6 µM scopoletin. Morin and scopoletin were initially dissolved in ethanol. Kinetic parameters, K m , and V max were obtained from line weaver-burk plot and the secondary plot was used for calculating K i values. The ultraviolet spectrum was recorded at room temperature on a sp-1200 uv spectrophotometer and 1 cm quartz cuvette.
Fluorescence Spectroscopy
Fluorescence spectroscopy studies were performed using Cary-Eclipse spectrofluorometer (Varian) measuring the fluorescence intensity of LDH (6.6 × 10 -3 µM) in the absence and presence of different concentrations of morin and scopoletin. The fluorescence spectra were recorded in a cuvette of 1 cm light path at room temperature. The excitation wavelength was 280 nm and emission wavelength was in the range of 300 to 400 nm. The LDH was titrated by the stock solution of inhibitors separately, so the LDH/morin molar ratios were 1: 0, 1: 100, 1: 250, 1: 500, 1: 750, 1: 1500, 1: 2000, 1: 2500, and 1: 3000 and the LDH/scopoletin molar ratios were 1: 0, 1: 50, 1: 100, 1: 150, 1: 200, and 1: 250.
Results
Essentially increasing of substrate concentration increases the activity of enzyme. Line weaver-Burk plot can be used to determine K m and V max values of the LDH enzyme (Figure 1 ). In the current experimental condition, the K m value was 11.69 mM and V max value was 1.258 mM/min for pyruvate. In the presence of both morin and scopoletin, the LDH activity was reduced. The kinetic analysis of LDH inhibition were identified from line weaver-burk plot. K m and V max values changed in the presence of different concentrations of each inhibitor. The secondary plot of slope versus [I] was used according to Equation 1 to determine K i .
(1)
Where, slope is (K m /V max ) of Lineweaver-Burk plot and [I] is inhibitor concentration. The K i value of morin was obtained as 1.78 µM and the K i value of scopoletin was 0.8 µM (Figure 2) .
Relative activity of the LDH enzyme was calculated in the presence of different concentrations of scopoletin and morin. As shown in Figure 3 , scopoletin inhibited LDH enzyme at lower concentrations compared to morin. IC50 values of LDH were found as 7.2 µM for morin and 1.7 µM for scopoletin. Therefore, scopoletin is a more potent LDH inhibitor than morin.
The intrinsic fluorescence has been widely used to study the interaction between ligands and proteins. Conformational changes of proteins alter microenvironment of aromatic residues like Trp, Tyr, and Phe. Trp is the major fluorophore of proteins intrinsic fluorescence and LDH has several Trp residues. The fluorescence spectrum of the native LDH shows a maximum at 342 nm. As shown in Figure 4 , increasing of the concentration of morin, decreased the LDH intrinsic fluorescence emission, consistently. The maximum emission wavelength was shifted in the presence of morin, so that 9 nm red shift was observed in the presence of 19.5 µM morin (Figure 4 ). This quenching and red shift indicated that morin could bind to and induce conformational changes in the LDH. The LDH quenching mechanism was investigated using Stern-Volmer Equation 2:
Where Figure 5 ). K (binding constant) and n (number of binding sites) was calculated using Equation 3 (25) . (3) log
The Equation 3 plot of log (F 0 -F)/F versus log [Morin] shows a slope of n and the vertical-intercept of logK. As shown in Figure 6 , K and n obtained from plot of morin binding to LDH were 1.568 × 10 4 M -1 and 0.84, respectively. As seen in Figure 7 , LDH intrinsic fluorescence emission was investigated in the presence of scopoletin 0 to 1.62 µM.
The fluorescence spectra of LDH were quenched by scopoletin and about 7 nm of red shift in the wavelength of maximum fluorescence emission was observed. K SV was calculated from slope of Stern-Volmer plot for scopoletin 2.164 Figure 8 ). According to Figure 9 , binding constant and number of binding sites of scopoletin on LDH were 642.6 M -1 and 0.57, respectively (26) . The fluorescence intensity of LDH decreased with increase in both inhibitors. By quenching of LDH with an increasing LDH/inhibitor ratio, the inhibitor interaction with LDH changed the microenvironment of Trp residues and tertiary structure of the enzyme.
Discussion
LDH interacts with morin and scopoletin and the effect of these two phenolic compounds on the activity and structure of LDH was investigated. Kinetic results indicate that both of these natural components inhibited LDH enzyme activity. Morin is structurally similar to some known LDH inhibitors, such as galoflavin and genistein. Comparison of Ki showed that inhibition potency of morin (Ki = 7.2 µM) is comparable to galloflavin (Ki = 5.46 µM) (5) and LDH was even better inhibited by scopoletin (Ki = 1.7 µM). Furthermore, scopoletin showed smaller IC50 value compared to morin and genistein (6) thus it can be introduced as a potent inhibitor of LDH.
Intrinsic fluorescence spectroscopy results showed that morin and scopoletin have the ability to bind to LDH and alter its conformation. Interaction of morin and scopoletin with LDH were of static type so inhibitors bind to LDH and approximately one inhibitor interacted with each LDH molecule. The current study observed a slight red shift in fluorescence intensity. In the presence of morin, maximum emission spectrum shifted to 351 nm (9 nm red shift) and in the presence of scopoletin shifted to 349 nm the amount of inhibition is not always directly subjected to structural changes. The limitation of this study was the use of ethanol as a solvent for morin and scopoletin because they are poorly soluble in water. In a separate experiment, the highest ethanol concentration (that was used) did not affect LDH activity, hence, it could be said that the observed changes were due to ligands not the ethanol present in the sample. In this study, morin changed the structure of the enzyme more than scopoletin, while scopoletin showed more effective inhibition. It is possible that morin and scopoletin mediated impairment of activity of lactate dehydrogenase and contributed to their anticancer properties. In conclusion, scopoletin might be a promising candidate in the field of tumor metabolism inhibitors, and deserves a more 
